14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.62 $2.30 Wednesday, 24th Apr 2024 CTMX stock ended at $1.63. This is 2.98% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.94% from a day low at $1.62 to a day high of $1.70.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Sep 19, 2023 $1.37 $1.38 $1.32 $1.35 127 473
Sep 18, 2023 $1.38 $1.40 $1.35 $1.37 143 571
Sep 15, 2023 $1.36 $1.39 $1.36 $1.38 111 792
Sep 14, 2023 $1.39 $1.39 $1.35 $1.38 107 449
Sep 13, 2023 $1.40 $1.43 $1.38 $1.38 120 193
Sep 12, 2023 $1.38 $1.41 $1.38 $1.40 68 310
Sep 11, 2023 $1.40 $1.40 $1.33 $1.37 179 667
Sep 08, 2023 $1.36 $1.39 $1.34 $1.39 157 276
Sep 07, 2023 $1.39 $1.41 $1.36 $1.38 172 509
Sep 06, 2023 $1.44 $1.44 $1.38 $1.38 214 530
Sep 05, 2023 $1.50 $1.51 $1.40 $1.42 225 402
Sep 01, 2023 $1.49 $1.54 $1.48 $1.50 129 794
Aug 31, 2023 $1.51 $1.52 $1.49 $1.50 45 036
Aug 30, 2023 $1.45 $1.50 $1.43 $1.49 141 528
Aug 29, 2023 $1.46 $1.50 $1.45 $1.45 152 192
Aug 28, 2023 $1.45 $1.49 $1.45 $1.45 28 644
Aug 25, 2023 $1.49 $1.50 $1.43 $1.46 117 856
Aug 24, 2023 $1.53 $1.53 $1.46 $1.48 151 954
Aug 23, 2023 $1.49 $1.54 $1.49 $1.52 81 454
Aug 22, 2023 $1.46 $1.51 $1.46 $1.48 66 352
Aug 21, 2023 $1.44 $1.51 $1.44 $1.48 212 673
Aug 18, 2023 $1.46 $1.51 $1.45 $1.47 206 649
Aug 17, 2023 $1.52 $1.54 $1.44 $1.49 379 261
Aug 16, 2023 $1.59 $1.60 $1.52 $1.54 263 762
Aug 15, 2023 $1.65 $1.68 $1.58 $1.59 321 049
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT